AU2016102323A4
|
|
Diazepam keto acid drug intermediates benzoic anhydride synthesis method
|
AU2016102315A4
|
|
Disopyramide drug intermediates 2-bromopyridine synthesis method
|
AU2016102324A4
|
|
Methotrexate drug intermediates malononitrile synthesis method
|
AU2016102321A4
|
|
Nizatidine drug intermediates 2-dimethyl amine methyl-4- chlorine methyl thiazole synthesis method
|
AU2016102318A4
|
|
Perhexiline drug intermediates α-(2,2- diphenyl-vinyl) pyridine synthesis method
|
AU2016102312A4
|
|
Clofibrate drug intermediates chlorophenoxy isobutyrate synthesis method
|
AU2016102317A4
|
|
Non-steroidal anti-inflammatory medicine diclofenac drug intermediates cyclohexene synthesis method
|
AU2016102325A4
|
|
Hexyl resorcinol drug intermediates 2-heptanone synthesis method
|
AU2016102314A4
|
|
Ceftezol drug intermediates 2-(1H-1-4 imidazolyl) acetic acid synthesis method
|
AU2016102316A4
|
|
Imidaclothiz drug intermediates 2-chloro-5-methyl thiazole synthesis method
|
AU2016102313A4
|
|
Deazapurine drug intermediates azide benzene synthesis method
|
AU2016102282A4
|
|
Fluorouracil drug intermediates 1-benzyl-5-amino uracil phthalocyanine synthesis method
|
AU2016102285A4
|
|
Anticancer compound FU-O-G pharmaceutical intermediate 2-benzyloxy-5-amino-pyrimidin-4-one synthesis method
|
AU2016102299A4
|
|
Atropine drug intermediates acetonedicarboxylic acid synthesis method
|
AU2016102295A4
|
|
Aminopterin sodium drug intermediates diethanol condensed acrolein synthesis method
|
AU2016102298A4
|
|
Buclizine drug intermediates 4-tert-butyl-benzyl chloride synthesis method
|
AU2016102300A4
|
|
Doxepin drug intermediates phthalic acid amide synthesis method
|
AU2016102278A4
|
|
Gastrodin pharmaceutical intermediate 4-formylphenyl-2,3,4,6- O- acetyl -β -D- glucopyranose glucoside synthesis method
|
AU2016102306A4
|
|
Tamoxifen drug intermediates epibromohydrin synthesis method
|
AU2016102293A4
|
|
Propafenone pharmaceutical intermediate 3- (α-ethyl benzyl) - 4 - hydroxyl coumarin synthesis method
|